Department of Medicine, Karolinska Institutet, Stockholm, Sweden; Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden.
Department of Clinical Science and Education, Karolinska Institutet, SöS, Stockholm, Sweden.
J Am Coll Cardiol. 2014 Feb 25;63(7):661-671. doi: 10.1016/j.jacc.2013.10.017. Epub 2013 Oct 30.
The purpose of this study was to evaluate simple criteria for referral of patients from the general practitioner to a heart failure (HF) center.
In advanced HF, the criteria for heart transplantation, left ventricular assist device, and palliative care are well known among HF specialists, but criteria for referral to an advanced HF center have not been developed for generalists.
We assessed observed and expected all-cause mortality in 10,062 patients with New York Heart Association (NYHA) functional class III to IV HF and ejection fraction <40% registered in the Swedish Heart Failure Registry between 2000 and 2013. Next, 5 pre-specified universally available risk factors were assessed as potential triggers for referral, using multivariable Cox regression: systolic blood pressure ≤90 mm Hg; creatinine ≥160 μmol/l; hemoglobin ≤120 g/l; no renin-angiotensin system antagonist; and no beta-blocker.
In NYHA functional class III to IV and age groups ≤65 years, 66 to 80 years, and >80 years, there were 2,247, 4,632, and 3,183 patients, with 1-year observed versus expected survivals of 90% versus 99%, 79% versus 97%, and 61% versus 89%, respectively. In the age ≤80 years group, the presence of 1, 2, or 3 to 5 of these risk factors conferred an independent hazard ratio for all-cause mortality of 1.40, 2.30, and 4.07, and a 1-year survival of 79%, 60%, and 39%, respectively (p < 0.001).
In patients ≤80 years of age with NYHA functional class III to IV HF and ejection fraction <40%, mortality is predominantly related to HF or its comorbidities. Potential heart transplantation/left ventricular assist device candidacy is suggested by ≥1 risk factor and potential palliative care by multiple universally available risk factors. These patients may benefit from referral to an advanced HF center.
本研究旨在评估将患者从全科医生转诊至心力衰竭(HF)中心的简单标准。
在晚期 HF 中,HF 专家熟知心脏移植、左心室辅助装置和姑息治疗的标准,但尚未为全科医生制定转诊至晚期 HF 中心的标准。
我们评估了 2000 年至 2013 年期间在瑞典心力衰竭注册中心登记的 NYHA 心功能 III 至 IV 级且射血分数<40%的 10062 例患者的实际和预期全因死亡率。接下来,使用多变量 Cox 回归评估了 5 个预先指定的普遍可用的风险因素作为转诊的潜在触发因素:收缩压≤90mmHg;肌酐≥160μmol/L;血红蛋白≤120g/L;无肾素-血管紧张素系统拮抗剂;和无β受体阻滞剂。
在 NYHA 心功能 III 至 IV 级和年龄≤65 岁、66 至 80 岁和>80 岁的患者中,分别有 2247、4632 和 3183 例患者,1 年观察生存率分别为 90%比 99%、79%比 97%和 61%比 89%。在年龄≤80 岁的患者中,存在 1、2 或 3 至 5 个这些危险因素时,全因死亡率的独立危险比分别为 1.40、2.30 和 4.07,1 年生存率分别为 79%、60%和 39%(p<0.001)。
在 NYHA 心功能 III 至 IV 级且射血分数<40%的年龄≤80 岁的 HF 患者中,死亡率主要与 HF 或其合并症有关。≥1 个危险因素提示潜在的心脏移植/左心室辅助装置候选者,多个普遍可用的危险因素提示潜在的姑息治疗。这些患者可能受益于转诊至晚期 HF 中心。